scholarly journals Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant

2018 ◽  
Vol 193 (2) ◽  
pp. 241-254 ◽  
Author(s):  
L. Zhu ◽  
M. Aly ◽  
H. Wang ◽  
H. Karakizlis ◽  
R. Weimer ◽  
...  
Keyword(s):  
Natural Killer Cell ◽  
Natural Killer ◽  
Kidney Transplant ◽  
Recurrent Miscarriage ◽  
Killer Cell ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Surface Receptors ◽  
Post Transplant

scholarly journals Natural killer cell function predicts severe infection in kidney transplant recipients

2018 ◽  
Vol 19 (1) ◽  
pp. 166-177 ◽  
Author(s):  
Claire Dendle ◽  
Poh‐Yi Gan ◽  
Kevan R. Polkinghorne ◽  
James Ngui ◽  
Rhonda L. Stuart ◽  
...  
Keyword(s):  
Natural Killer Cell ◽  
Natural Killer ◽  
Kidney Transplant ◽  
Cell Function ◽  
Killer Cell ◽  
Severe Infection ◽  
Transplant Recipients ◽  
Natural Killer Cell Function ◽  
Kidney Transplant Recipients

scholarly journals Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications

2015 ◽  
Vol 88 (6) ◽  
pp. 1374-1382 ◽  
Author(s):  
Christopher M. Hope ◽  
Alexander Troelnikov ◽  
William Hanf ◽  
Shilpanjali Jesudason ◽  
Patrick T. Coates ◽  
...  
Keyword(s):  
T Cell ◽  
Natural Killer Cell ◽  
Cancer Risk ◽  
Natural Killer ◽  
Kidney Transplant ◽  
Cell Function ◽  
Killer Cell ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
T Cell Function

scholarly journals Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study

2017 ◽  
Vol 31 (2) ◽  
pp. 187-197 ◽  
Author(s):  
Mario Fernández-Ruiz ◽  
Julia Origüen ◽  
David Lora ◽  
Francisco López-Medrano ◽  
Esther González ◽  
...  
Keyword(s):  
Cohort Study ◽  
Herpes Zoster ◽  
Natural Killer Cell ◽  
Protective Effect ◽  
Cell Count ◽  
Natural Killer ◽  
Killer Cell ◽  
Transplant Recipients ◽  
Single Center ◽  
Kidney Transplant Recipients

scholarly journals Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients

Pharmaceutics ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 413
Author(s):  
Theerawut Klangjareonchai ◽  
Natsuki Eguchi ◽  
Ekamol Tantisattamo ◽  
Antoney J. Ferrey ◽  
Uttam Reddy ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Kidney Transplantation ◽  
Kidney Transplant ◽  
Pharmacological Intervention ◽  
Diabetic Patients ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Kidney Allograft ◽  
Post Transplant ◽  
Glucose Management

Hyperglycemia after kidney transplantation is common in both diabetic and non-diabetic patients. Both pretransplant and post-transplant diabetes mellitus are associated with increased kidney allograft failure and mortality. Glucose management may be challenging for kidney transplant recipients. The pathophysiology and pattern of hyperglycemia in patients following kidney transplantation is different from those with type 2 diabetes mellitus. In patients with pre-existing and post-transplant diabetes mellitus, there is limited data on the management of hyperglycemia after kidney transplantation. The following article discusses the nomenclature and diagnosis of pre- and post-transplant diabetes mellitus, the impact of transplant-related hyperglycemia on patient and kidney allograft outcomes, risk factors and potential pathogenic mechanisms of hyperglycemia after kidney transplantation, glucose management before and after transplantation, and modalities for prevention of post-transplant diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document